A detailed history of First Republic Investment Management, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 20,832 shares of NTRA stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,832
Holding current value
$3.04 Million
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$43.4 - $62.52 $904,108 - $1.3 Million
20,832 New
20,832 $921,000
Q1 2023

May 11, 2023

SELL
$36.57 - $58.29 $283,966 - $452,621
-7,765 Reduced 20.52%
30,084 $1.67 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $102,099 - $143,155
2,988 Added 8.57%
37,849 $1.52 Million
Q3 2022

Nov 03, 2022

BUY
$36.93 - $56.68 $107,872 - $165,562
2,921 Added 9.15%
34,861 $1.53 Million
Q2 2022

Aug 16, 2022

BUY
$28.13 - $44.54 $160,678 - $254,412
5,712 Added 21.78%
31,940 $1.13 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $159,513 - $480,487
-5,261 Reduced 16.71%
26,228 $1.07 Million
Q4 2021

Feb 09, 2022

SELL
$86.26 - $119.0 $370,486 - $511,105
-4,295 Reduced 12.0%
31,489 $2.94 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $120,304 - $151,758
1,201 Added 3.47%
35,784 $3.99 Million
Q2 2021

Aug 16, 2021

BUY
$86.05 - $119.72 $1.15 Million - $1.6 Million
13,369 Added 63.02%
34,583 $3.93 Million
Q1 2021

May 14, 2021

SELL
$91.47 - $124.36 $3.45 Million - $4.69 Million
-37,746 Reduced 64.02%
21,214 $2.15 Million
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $2.75 Million - $4.61 Million
41,266 Added 233.22%
58,960 $5.87 Million
Q3 2020

Nov 12, 2020

BUY
$45.89 - $72.67 $248,264 - $393,144
5,410 Added 44.04%
17,694 $1.28 Million
Q2 2020

Aug 13, 2020

BUY
$26.36 - $49.86 $323,806 - $612,480
12,284 New
12,284 $612,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.